306 related articles for article (PubMed ID: 37319001)
21. KmrA multidrug efflux pump from Klebsiella pneumoniae.
Ogawa W; Koterasawa M; Kuroda T; Tsuchiya T
Biol Pharm Bull; 2006 Mar; 29(3):550-3. PubMed ID: 16508165
[TBL] [Abstract][Full Text] [Related]
22. Metabolic Compensation of Fitness Costs Is a General Outcome for Antibiotic-Resistant
Olivares Pacheco J; Alvarez-Ortega C; Alcalde Rico M; Martínez JL
mBio; 2017 Jul; 8(4):. PubMed ID: 28743808
[TBL] [Abstract][Full Text] [Related]
23. Emergence of a Plasmid-Encoded Resistance-Nodulation-Division Efflux Pump Conferring Resistance to Multiple Drugs, Including Tigecycline, in Klebsiella pneumoniae.
Lv L; Wan M; Wang C; Gao X; Yang Q; Partridge SR; Wang Y; Zong Z; Doi Y; Shen J; Jia P; Song Q; Zhang Q; Yang J; Huang X; Wang M; Liu JH
mBio; 2020 Mar; 11(2):. PubMed ID: 32127452
[TBL] [Abstract][Full Text] [Related]
24. Promiscuous partnering and independent activity of MexB, the multidrug transporter protein from Pseudomonas aeruginosa.
Welch A; Awah CU; Jing S; van Veen HW; Venter H
Biochem J; 2010 Sep; 430(2):355-64. PubMed ID: 20583998
[TBL] [Abstract][Full Text] [Related]
25. Mutations in MexB that affect the efflux of antibiotics with cytoplasmic targets.
Ohene-Agyei T; Lea JD; Venter H
FEMS Microbiol Lett; 2012 Aug; 333(1):20-7. PubMed ID: 22568688
[TBL] [Abstract][Full Text] [Related]
26. Biochemical Reconstitution and Characterization of Multicomponent Drug Efflux Transporters.
Picard M; Tikhonova EB; Broutin I; Lu S; Verchère A; Zgurskaya HI
Methods Mol Biol; 2018; 1700():113-145. PubMed ID: 29177829
[TBL] [Abstract][Full Text] [Related]
27. The MexJK Multidrug Efflux Pump Is Not Involved in Acquired or Intrinsic Antibiotic Resistance in
Amieva R; Gil-Gil T; Martínez JL; Alcalde-Rico M
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35886841
[TBL] [Abstract][Full Text] [Related]
28. Quantitative contribution of efflux to multi-drug resistance of clinical Escherichia coli and Pseudomonas aeruginosa strains.
Cunrath O; Meinel DM; Maturana P; Fanous J; Buyck JM; Saint Auguste P; Seth-Smith HMB; Körner J; Dehio C; Trebosc V; Kemmer C; Neher R; Egli A; Bumann D
EBioMedicine; 2019 Mar; 41():479-487. PubMed ID: 30852163
[TBL] [Abstract][Full Text] [Related]
29. Substrate specificity of the RND-type multidrug efflux pumps AcrB and AcrD of Escherichia coli is determined predominantly by two large periplasmic loops.
Elkins CA; Nikaido H
J Bacteriol; 2002 Dec; 184(23):6490-8. PubMed ID: 12426336
[TBL] [Abstract][Full Text] [Related]
30. Antibiotic Substrate Selectivity of Pseudomonas aeruginosa MexY and MexB Efflux Systems Is Determined by a Goldilocks Affinity.
Dey D; Kavanaugh LG; Conn GL
Antimicrob Agents Chemother; 2020 Jul; 64(8):. PubMed ID: 32457110
[TBL] [Abstract][Full Text] [Related]
31. Metabolomics Reveal Potential Natural Substrates of AcrB in Escherichia coli and Salmonella enterica Serovar Typhimurium.
Wang-Kan X; Rodríguez-Blanco G; Southam AD; Winder CL; Dunn WB; Ivens A; Piddock LJV
mBio; 2021 Mar; 12(2):. PubMed ID: 33785633
[TBL] [Abstract][Full Text] [Related]
32. Transcriptional Analysis of MexAB-OprM Efflux Pumps System of Pseudomonas aeruginosa and Its Role in Carbapenem Resistance in a Tertiary Referral Hospital in India.
Choudhury D; Das Talukdar A; Dutta Choudhury M; Maurya AP; Paul D; Dhar Chanda D; Chakravorty A; Bhattacharjee A
PLoS One; 2015; 10(7):e0133842. PubMed ID: 26221722
[TBL] [Abstract][Full Text] [Related]
33. Making sense of drug-efflux transporters in the physiological environment.
Zgurskaya HI; Adamiak JW; Leus IV
Curr Opin Microbiol; 2022 Oct; 69():102179. PubMed ID: 35882103
[TBL] [Abstract][Full Text] [Related]
34. Efflux pump-mediated antibiotics resistance: insights from computational structural biology.
Fischer N; Raunest M; Schmidt TH; Koch DC; Kandt C
Interdiscip Sci; 2014 Mar; 6(1):1-12. PubMed ID: 24464699
[TBL] [Abstract][Full Text] [Related]
35. AcrB drug-binding pocket substitution confers clinically relevant resistance and altered substrate specificity.
Blair JM; Bavro VN; Ricci V; Modi N; Cacciotto P; Kleinekathӧfer U; Ruggerone P; Vargiu AV; Baylay AJ; Smith HE; Brandon Y; Galloway D; Piddock LJ
Proc Natl Acad Sci U S A; 2015 Mar; 112(11):3511-6. PubMed ID: 25737552
[TBL] [Abstract][Full Text] [Related]
36. Evidence that a novel quaternary compound and its organic N-chloramine derivative do not select for resistant mutants of Pseudomonas aeruginosa.
De Silva M; Ning C; Ghanbar S; Zhanel G; Logsetty S; Liu S; Kumar A
J Hosp Infect; 2015 Sep; 91(1):53-8. PubMed ID: 26122622
[TBL] [Abstract][Full Text] [Related]
37. A new member of the tripartite multidrug efflux pumps, MexVW-OprM, in Pseudomonas aeruginosa.
Li Y; Mima T; Komori Y; Morita Y; Kuroda T; Mizushima T; Tsuchiya T
J Antimicrob Chemother; 2003 Oct; 52(4):572-5. PubMed ID: 12951344
[TBL] [Abstract][Full Text] [Related]
38. Gene cloning and characteristics of the RND-type multidrug efflux pump MuxABC-OpmB possessing two RND components in Pseudomonas aeruginosa.
Mima T; Kohira N; Li Y; Sekiya H; Ogawa W; Kuroda T; Tsuchiya T
Microbiology (Reading); 2009 Nov; 155(Pt 11):3509-3517. PubMed ID: 19713238
[TBL] [Abstract][Full Text] [Related]
39. Phenotype microarray analysis of the drug efflux systems in Salmonella enterica serovar Typhimurium.
Yamasaki S; Fujioka T; Hayashi K; Yamasaki S; Hayashi-Nishino M; Nishino K
J Infect Chemother; 2016 Nov; 22(11):780-784. PubMed ID: 27210311
[TBL] [Abstract][Full Text] [Related]
40. Non-antibiotics, Efflux Pumps and Drug Resistance of Gram-negative Rods.
Laudy AE
Pol J Microbiol; 2018 Jun; 67(2):129-135. PubMed ID: 30015451
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
